Physician profile
Itai Gans
NPI 1982015236
$21,296.92
in general payments reported to CMS, 2019-2025
26 companies · $508 in 2025
The $508 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,520 · 2021: $3,678 · 2022: $4,538 · 2023: $343 · 2024: $468 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,319.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $12,236.36 | 2019-2022 | |
| Liberty Surgical INC. | $4,504.47 | 2020-2022 | |
| Stryker Corporation | $2,907.04 | 2019-2025 | Gamma, Pangea |
| Zimmer Biomet Holdings, INC. | $207.66 | 2022-2025 | Juggerknotless Soft Anchor |
| Vericel Corporation | $168.78 | 2020-2023 | Maci |
| Miach Orthopaedics, INC. | $157.69 | 2024 | |
| Ferring Pharmaceuticals INC. | $125.72 | 2023-2025 | Euflexxa |
| Innovation Technologies INC | $97.73 | 2024 | Irrisept |
| Acumed LLC | $93.84 | 2019 | |
| Depuy Synthes Sales INC. | $81.78 | 2020-2024 | Monovisc, Orthovisc |
| Arcuro Medical INC | $80.90 | 2024 | Superball |
| Linvatec Corporation | $77.01 | 2020 | |
| Ani Pharmaceuticals, INC. | $71.82 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $69.61 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Heraeus Medical, LLC. | $65.11 | 2023-2025 | Palacos |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $53.15 | 2022-2025 | Na, Acufex |
| Trice Medical, INC. | $47.81 | 2024 | |
| Ibsa Pharma INC. | $47.16 | 2024-2025 | Licart, Tirosint, Flector |
| Avanos Medical | $42.88 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $36.64 | 2025 | |
| Horizon Therapeutics Plc | $36.54 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $21.22 | 2023 | |
| Pacira Therapeutics, INC. | $19.90 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.84 | 2025 | Nuzyra |
| Alexion Pharmaceuticals, INC. | $15.20 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.06 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itai Gans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.